Evidence-based guidelines for asthma care
Global Initiative for Asthma (GINA) (ginasthma.org) scores 78 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Non-profit brands, Education brands, in the 58th percentile of 10206 Healthcare brands.
Global Initiative for Asthma (GINA) is a nonprofit organization that develops evidence-based strategy documents, reports, and educational resources for asthma diagnosis and management. It collaborates with healthcare professionals and public health officials worldwide to standardize asthma care and reduce its prevalence, morbidity, and mortality. GINA is widely recognized as a leading global authority on asthma guidelines, serving clinicians, researchers, and policymakers.
| Brand Name | Global Initiative for Asthma (GINA) |
|---|---|
| Domain | ginasthma.org |
| Industry | Healthcare, Non-profit |
| Main Competitors | Global Initiative for Chronic Obstructive Lung Disease (GOLD) (79/100), American Thoracic Society (87/100), European Respiratory Society (86/100), National Heart, Lung, and Blood Institute (NAEPP), World Health Organization (93/100) |
Moz Domain Authority 62/100 vs category average 41 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #118,698 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "We work with health care professionals and public health officials around the globe to reduce asthma prevalence, morbidity, and mortality." (Meta description: 20 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, + Microdata, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost.
Social footprint: verified profiles on X (Twitter), LinkedIn, Instagram; no detected presence on Facebook, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Global Initiative for Asthma (GINA)?", Claude could identify the brand as of September 2026. GINA is a global program launched in collaboration with the National Institutes of Health and the World Health Organization to develop and disseminate evidence-based guidelines for asthma management and prevention. It publishes an annual strategy report that is widely used by cli Best known for Publishing the internationally recognized annual asthma management guidelines used by clinicians worldwide.
When asked "Best brands similar to Global Initiative for Asthma (GINA)?", Claude would recommend Global Initiative for Asthma (GINA) as of September 2026. If someone asked about authoritative sources on asthma treatment guidelines, GINA is one of the most respected and widely cited references in the field.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Global Initiative for Asthma (GINA)'s main competitors in Healthcare: Global Initiative for Chronic Obstructive Lung Disease (GOLD) (79/100), American Thoracic Society (87/100), European Respiratory Society (86/100), World Health Organization (93/100).
Sources: Brand Analyzer scan
Global Initiative for Asthma (GINA) has limited AI-search visibility, scoring 39/100 on Brand Analyzer's AI visibility composite (visibility 18, trust 56, recommendation 58). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Global Initiative for Asthma (GINA) scores 58/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
GINA offers strategy documents, reports, and educational resources related to asthma diagnosis and management, designed for use by healthcare professionals, researchers, and policymakers.
GINA (Global Initiative for Asthma) is a nonprofit organization that produces evidence-based guidelines and educational materials on asthma diagnosis and management, used by healthcare professionals and public health officials globally.
Global Initiative for Asthma (GINA) can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
GINA's resources are used by healthcare professionals, public health officials, medical researchers, and organizations involved in asthma diagnosis, treatment, and policy-making worldwide.
Global Initiative for Asthma (GINA) scores 39/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Global Initiative for Asthma (GINA) has a weak AI-visibility profile at 39/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (58/100) and its weakest is visibility (18/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #118,698 (Tranco) and a Moz Domain Authority of 62/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Global Initiative for Asthma (GINA) from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Global Initiative for Asthma (GINA): ReferralMD (78/100), DUOS (78/100), Gladstone Institutes (78/100), Global Medics (78/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.